Search - tctmd.com

Displaying 581 - 600 of 671

Sort: Relevancy | Date

Presentation

Efficacy and Safety of Intensified Antiplatelet Therapy Based on Reactivity Testing After PCI

Presenter: D?niel Aradi

July 11, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

Presentation

Comparison of Abciximab vs. Eptifibatide During PCI in STEMI (from the HORIZONS-AMI Trial)

Presenter: H. S. Singh

July 05, 2012

Presentation

Cost-Effectiveness of Treating ACS Patients with Ticagrelor for 12 Months

Presenter: Elisabet Nikolic

June 25, 2012

Presentation

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

Presenter: 204599|MP Bonaca

June 22, 2012

Presentation

Periprocedural Bleeding and Thromboembolic Events with Dabigatran Compared to Warfarin

Presenter: Jeff S. Healey

June 21, 2012

Presentation

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients

Presenter: Matthew J. Price

June 13, 2012

Presentation

Prolonged Clopidogrel Use After BMS and DES Placement: The VA Drug-Eluting Stent Study

Presenter: David P. Faxon

June 08, 2012

Presentation

Prognostic Value of High On-Clopidogrel Platelet Reactivity in Bivalirudin- vs. Abciximab-Treated NSTEMI Patients

Presenter: Dirk Sibbing

June 06, 2012

Presentation

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

Presenter: R. Piccolo

June 04, 2012

Presentation

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

Presenter: T. Tada

June 01, 2012

Presentation

Ticagrelor vs. Clopidogrel in Patients with ACS and a History of Stroke or TIA

Presenter: Stefan K. James

May 31, 2012

Presentation TCT Russia 2012

Acute Care Approch to PCI Intervention: the Interventional Phamacology Menu

Presenter: Pawel Buszman

May 28, 2012

Presentation

Mortality Benefit with Prasugrel in the TRITON-TIMI 38 CABG Cohort

Presenter: 195949|Peter Smith

May 25, 2012

Presentation

Influence of Genetic Polymorphisms on High- and Standard-Dose Clopidogrel After PCI

Presenter: Matthew J. Price

May 22, 2012

Presentation EuroPCR 2012

ROMA II Reload

Presenter: G. Sardella

May 17, 2012

Presentation TCT Mediterranean 2012

Anticoagulation in ACS: Role of Bivalirudin

Presenter: Gregg W. Stone

May 04, 2012

Presentation

PHARAOH: Effect of A Priori vs. Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

Presenter: Samir B. Pancholy

April 26, 2012

Presentation TCTAP 2012

P2Y12 Receptor Inhibitors: Which Drug and for Whom?

Presenter: Cheol Whan Lee

April 26, 2012

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

Advertisement

Efficacy and Safety of Intensified Antiplatelet Therapy Based on Reactivity Testing After PCI

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Comparison of Abciximab vs. Eptifibatide During PCI in STEMI (from the HORIZONS-AMI Trial)

Cost-Effectiveness of Treating ACS Patients with Ticagrelor for 12 Months

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

Periprocedural Bleeding and Thromboembolic Events with Dabigatran Compared to Warfarin

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients

Prolonged Clopidogrel Use After BMS and DES Placement: The VA Drug-Eluting Stent Study

Prognostic Value of High On-Clopidogrel Platelet Reactivity in Bivalirudin- vs. Abciximab-Treated NSTEMI Patients

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

Ticagrelor vs. Clopidogrel in Patients with ACS and a History of Stroke or TIA

Acute Care Approch to PCI Intervention: the Interventional Phamacology Menu

Mortality Benefit with Prasugrel in the TRITON-TIMI 38 CABG Cohort

Influence of Genetic Polymorphisms on High- and Standard-Dose Clopidogrel After PCI

ROMA II Reload

Anticoagulation in ACS: Role of Bivalirudin

PHARAOH: Effect of A Priori vs. Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

P2Y12 Receptor Inhibitors: Which Drug and for Whom?

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content